Calretinin is a novel candidate marker for adverse ovarian effects of early life exposure to mixtures of endocrine disruptors in the rat (2020)

First Author: Johansson H

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s00204-020-02697-3

PubMed Identifier: 32221642

Publication URI: http://europepmc.org/abstract/MED/32221642

Type: Journal Article/Review

Parent Publication: Archives of Toxicology

Issue: 4

ISSN: 0340-5761